Ameritas Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Sell
3,592
-10
-0.3% -$6.41K 0.06% 342
2025
Q4
$2.44M Buy
3,602
+205
+6% +$140K 0.07% 280
2025
Q3
$2.17M Buy
3,397
+3
+0.1% +$1.82K 0.07% 309
2025
Q2
$1.82M Sell
3,394
-66
-2% -$31.6K 0.06% 374
2025
Q1
$1.45M Buy
3,460
+57
+2% +$24.8K 0.05% 457
2024
Q4
$1.41M Buy
3,403
+92
+3% +$40.4K 0.05% 493
2024
Q3
$1.67M Buy
3,311
+44
+1% +$21.4K 0.05% 416
2024
Q2
$1.59M Sell
3,267
-40
-1% -$20.1K 0.05% 409
2024
Q1
$1.79M Sell
3,307
-25
-0.8% -$13.7K 0.06% 380
2023
Q4
$1.85M Buy
3,332
+49
+1% +$23K 0.07% 331
2023
Q3
$1.44M Buy
3,283
+497
+18% +$248K 0.06% 401
2023
Q2
$1.4M Sell
2,786
-15
-0.5% -$7.19K 0.05% 447
2023
Q1
$1.4M Buy
2,801
+16
+0.6% +$7.66K 0.06% 432
2022
Q4
$1.38M Sell
2,785
-92
-3% -$35.7K 0.06% 459
2022
Q3
$937K Sell
2,877
-57
-2% -$20.9K 0.04% 540
2022
Q2
$1.03M Hold
2,934
0.04% 517
2022
Q1
$1.6M Sell
2,934
-30
-1% -$15.8K 0.06% 412
2021
Q4
$1.95M Buy
2,964
+11
+0.4% +$6.91K 0.07% 345
2021
Q3
$1.84M Sell
2,953
-48
-2% -$32.3K 0.07% 338
2021
Q2
$1.9M Buy
3,001
+29
+1% +$16K 0.07% 329
2021
Q1
$1.45M Sell
2,972
-41
-1% -$20.5K 0.06% 422
2020
Q4
$1.51M Buy
3,013
+84
+3% +$37.6K 0.07% 363
2020
Q3
$1.15M Sell
2,929
-111
-4% -$41K 0.05% 405
2020
Q2
$1M Sell
3,040
-101
-3% -$29.2K 0.05% 457
2020
Q1
$761K Hold
3,141
0.04% 467
2019
Q4
$820K Buy
3,141
+35
+1% +$9.22K 0.04% 589
2019
Q3
$845K Hold
3,106
0.04% 566
2019
Q2
$855K Sell
3,106
-57
-2% -$14K 0.04% 574
2019
Q1
$707K Hold
3,163
0.03% 640
2018
Q4
$588K Buy
3,163
+61
+2% +$12.5K 0.03% 653
2018
Q3
$774K Sell
3,102
-139
-4% -$33.7K 0.04% 621
2018
Q2
$706K Sell
3,241
-154
-5% -$31.7K 0.03% 650
2018
Q1
$650K Sell
3,395
-76
-2% -$14K 0.03% 677
2017
Q4
$543K Sell
3,471
-136
-4% -$21.4K 0.02% 723
2017
Q3
$560K Hold
3,607
0.03% 713
2017
Q2
$582K Hold
3,607
0.03% 718
2017
Q1
$558K Sell
3,607
-23,376
-87% -$3.22M 0.03% 736
2016
Q4
$3.16M Hold
26,983
0.16% 125
2016
Q3
$3.04M Buy
26,983
+12,827
+91% +$1.35M 0.17% 109
2016
Q2
$1.31M Buy
14,156
+582
+4% +$50K 0.09% 226
2016
Q1
$1.06M Sell
13,574
-247
-2% -$17.8K 0.07% 285
2015
Q4
$1.01M Hold
13,821
0.07% 293
2015
Q3
$1.03M Sell
13,821
-287
-2% -$20.6K 0.07% 272
2015
Q2
$905K Hold
14,108
0.06% 331
2015
Q1
$1.09M Hold
14,108
0.07% 280
2014
Q4
$1.05M Sell
14,108
-770
-5% -$54K 0.07% 276
2014
Q3
$877K Sell
14,878
-402
-3% -$25.4K 0.06% 321
2014
Q2
$1.02M Sell
15,280
-468
-3% -$29.8K 0.07% 283
2014
Q1
$956K Sell
15,748
-602
-4% -$35.9K 0.08% 303
2013
Q4
$870K Sell
16,350
-306
-2% -$16.1K 0.07% 337
2013
Q3
$830K Buy
+16,656
New +$801K 0.08% 322

Other funds holding IDXX

Ameritas Investment Partners's IDXX Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Idexx Laboratories (IDXX) stake by 0.28% in Q1 2026, selling an estimated $6.41K and leaving 3,592 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #342.

Ameritas Investment Partners first reported a position in IDXX in Q3 2013 and has held it in 51 quarters since. The position peaked at $3.16M in Q4 2016. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Ameritas Investment Partners held 3,592 shares of Idexx Laboratories worth $2.02M as of Q1 2026.
  • Ameritas Investment Partners sold 10 Idexx Laboratories shares in Q1 2026, an estimated $6.41K.
  • Idexx Laboratories made up 0.06% of Ameritas Investment Partners's portfolio in Q1 2026, its #342 holding.
  • Ameritas Investment Partners first reported a position in Idexx Laboratories in Q3 2013 and has held it in 51 quarters since.
  • Ameritas Investment Partners's Idexx Laboratories position peaked at $3.16M in Q4 2016.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.